About Genexis Biotech
Genexis Biotech is a company based in Vadodara (India) founded in 2019 by Jitendra Wagh and Vipul Kumar. Genexis Biotech has raised $611.34 thousand across 3 funding rounds from investors including Gujarat Venture Finance, Indigram Labs and Benzai10 Investment Ventures. Genexis Biotech offers products and services including FBS Alternative, Growth Factors, Animal Origin-Free Proteins, and Cell Culture Media. Genexis Biotech operates in a competitive market with competitors including Abcam, Stem Cell Technologies, Meridian Bioscience, Teknova and Sangon Biotech, among others.
- Headquarter Vadodara, India
- Founders Jitendra Wagh, Vipul Kumar
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Genexis Biotech Private Limited
- Date of Incorporation 14 Oct, 2019
- Jurisdiction Vadodara, Gujarat, India
-
Annual Revenue
$201.01 K (USD)225.39as on Mar 31, 2022
-
Net Profit
$13.63 K (USD)327.97as on Mar 31, 2022
-
EBITDA
$47.89 K (USD)149.98as on Mar 31, 2022
-
Total Equity Funding
$611.34 K (USD)
in 3 rounds
-
Latest Funding Round
$462.35 K (USD), Seed
Jul 28, 2025
-
Investors
Gujarat Venture Finance
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Genexis Biotech
Genexis Biotech offers a comprehensive portfolio of products and services, including FBS Alternative, Growth Factors, Animal Origin-Free Proteins, and Cell Culture Media.
Sustainable serum-free solution for robust cell growth applications.
Engineered for optimal cell growth in research and production.
High-quality proteins via fermentation for ethical applications.
Supports tissue engineering and drug development processes.
Funding Insights of Genexis Biotech
Genexis Biotech has successfully raised a total of $611.34K across 3 strategic funding rounds. The most recent funding activity was a Seed round of $462.35 thousand completed in July 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Genexis Biotech
Genexis Biotech has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Gujarat Venture Finance, Indigram Labs and Benzai10 Investment Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Provider of agriculture investment services
|
Locked | Locked | Locked | |
|
Incubation and support for startups in agritech, foodtech, clean tech, and rural healthcare sectors.
|
Locked | Locked | Locked | |
|
Venture capital investments are made in Indian startups across multiple sectors.
|
Locked | Locked | Locked |
Investor details for Genexis Biotech
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Genexis Biotech
Investment portfolio details for Genexis Biotech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Genexis Biotech
Detailed financials for Genexis Biotech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Genexis Biotech Comparisons
Peer comparison for Genexis Biotech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Genexis Biotech
Genexis Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Stem Cell Technologies, Meridian Bioscience, Teknova and Sangon Biotech, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Biological reagents and antibodies are developed for life science research.
|
|
| Locked | Locked | Locked |
Developer of cell culture media and ancillary reagents for life science research
|
|
| Locked | Locked | Locked |
Molecular diagnostic device and kits
|
|
| Locked | Locked | Locked |
Molecular biology reagents and kits are supplied for research applications.
|
|
| Locked | Locked | Locked |
Research services, reagents, and kits for biotech applications are provided.
|
|
| Locked | Locked | Locked |
Bioreagents and assay kits are developed, with preclinical services provided.
|
Detailed competitors of Genexis Biotech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Genexis Biotech
Complete news archive for Genexis Biotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Genexis Biotech
Genexis Biotech was founded in 2019 and raised its 1st funding round 4 years after it was founded.
Genexis Biotech is headquartered in Vadodara, India. It is registered at Vadodara, Gujarat, India.
Genexis Biotech is a funded company, having raised a total of $611.34K across 3 funding rounds to date.
Annual revenue of Genexis Biotech is $201.01K as on Mar 31, 2022.
Genexis Biotech was established in 2019 in Vadodara, India, within the biotechnology sector. Full-spectrum services in microbiology, molecular biology, and microbial fermentation solutions are delivered. Precision fermentation and cell culture-based technologies are employed to create alternative proteins via biological platforms. Operations focus on addressing biotechnology requirements through these methods.
Genexis Biotech's top competitors include Abcam, Meridian Bioscience and Stem Cell Technologies.
Genexis Biotech offers FBS Alternative, Growth Factors, Animal Origin-Free Proteins, and Cell Culture Media.
Genexis Biotech has 3 investors. Key investors include Gujarat Venture Finance, Indigram Labs, and Benzai10 Investment Ventures.
The valuation of Genexis Biotech is $2.74M as of Oct 2024.